APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genital Herpes Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Genital Herpes Vaccine Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchGenital Herpes Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Genital Herpes Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Genital Herpes Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genital Herpes Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Genital Herpes Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Genital Herpes Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Genital Herpes Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Genital Herpes Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Genital Herpes Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Genital Herpes Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Genital Herpes Vaccine include GSK, Changsheng Biotechnology, Merck, Beike Bio and BioNTech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Genital Herpes Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Genital Herpes Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Genital Herpes Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Genital Herpes Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Genital Herpes Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Genital Herpes Vaccine sales, projected growth trends, production technology, application and end-user industry.

Genital Herpes Vaccine Segment by Company

GSK

Changsheng Biotechnology

Merck

Beike Bio

BioNTech

Genital Herpes Vaccine Segment by Type

Zoster Vaccine Live

Recombinant Zoster Vaccine

Genital Herpes Vaccine Segment by Application

Male

Female

Genital Herpes Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genital Herpes Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genital Herpes Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genital Herpes Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Genital Herpes Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Genital Herpes Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genital Herpes Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Genital Herpes Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Zoster Vaccine Live Major Manufacturers Table 3. Recombinant Zoster Vaccine Major Manufacturers Table 4. Global Genital Herpes Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Male Major Manufacturers Table 6. Female Major Manufacturers Table 7. Genital Herpes Vaccine Industry Trends Table 8. Genital Herpes Vaccine Industry Drivers Table 9. Genital Herpes Vaccine Industry Opportunities and Challenges Table 10. Genital Herpes Vaccine Industry Restraints Table 11. Global Genital Herpes Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Genital Herpes Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Genital Herpes Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Genital Herpes Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Genital Herpes Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Genital Herpes Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Genital Herpes Vaccine Sales by Region (2021-2026) & (k units) Table 18. Global Genital Herpes Vaccine Sales by Region (2027-2032) & (k units) Table 19. Global Genital Herpes Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Genital Herpes Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Genital Herpes Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Genital Herpes Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Genital Herpes Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Genital Herpes Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Genital Herpes Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Genital Herpes Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Genital Herpes Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Genital Herpes Vaccine Manufacturers, Product Type & Application Table 29. Global Genital Herpes Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Genital Herpes Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Genital Herpes Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Genital Herpes Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Genital Herpes Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Genital Herpes Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Genital Herpes Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Genital Herpes Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Genital Herpes Vaccine Sales by Type (2021-2026) & (k units) Table 39. Global Genital Herpes Vaccine Sales by Type (2027-2032) & (k units) Table 40. Global Genital Herpes Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Genital Herpes Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Genital Herpes Vaccine Price by Type (2021-2026) & (US$/unit) Table 43. Global Genital Herpes Vaccine Price by Type (2027-2032) & (US$/unit) Table 44. Global Genital Herpes Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Genital Herpes Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Genital Herpes Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Genital Herpes Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Genital Herpes Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Genital Herpes Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Genital Herpes Vaccine Sales by Application (2021-2026) & (k units) Table 51. Global Genital Herpes Vaccine Sales by Application (2027-2032) & (k units) Table 52. Global Genital Herpes Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Genital Herpes Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Genital Herpes Vaccine Price by Application (2021-2026) & (US$/unit) Table 55. Global Genital Herpes Vaccine Price by Application (2027-2032) & (US$/unit) Table 56. GSK Company Information Table 57. GSK Business Overview Table 58. GSK Genital Herpes Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. GSK Genital Herpes Vaccine Product Portfolio Table 60. GSK Recent Development Table 61. Changsheng Biotechnology Company Information Table 62. Changsheng Biotechnology Business Overview Table 63. Changsheng Biotechnology Genital Herpes Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Changsheng Biotechnology Genital Herpes Vaccine Product Portfolio Table 65. Changsheng Biotechnology Recent Development Table 66. Merck Company Information Table 67. Merck Business Overview Table 68. Merck Genital Herpes Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Merck Genital Herpes Vaccine Product Portfolio Table 70. Merck Recent Development Table 71. Beike Bio Company Information Table 72. Beike Bio Business Overview Table 73. Beike Bio Genital Herpes Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Beike Bio Genital Herpes Vaccine Product Portfolio Table 75. Beike Bio Recent Development Table 76. BioNTech Company Information Table 77. BioNTech Business Overview Table 78. BioNTech Genital Herpes Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. BioNTech Genital Herpes Vaccine Product Portfolio Table 80. BioNTech Recent Development Table 81. North America Genital Herpes Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Genital Herpes Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Genital Herpes Vaccine Sales by Type (2021-2026) & (k units) Table 84. North America Genital Herpes Vaccine Sales by Type (2027-2032) & (k units) Table 85. North America Genital Herpes Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 86. North America Genital Herpes Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 87. North America Genital Herpes Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Genital Herpes Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Genital Herpes Vaccine Sales by Application (2021-2026) & (k units) Table 90. North America Genital Herpes Vaccine Sales by Application (2027-2032) & (k units) Table 91. North America Genital Herpes Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 92. North America Genital Herpes Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 93. North America Genital Herpes Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Genital Herpes Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 95. North America Genital Herpes Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 96. North America Genital Herpes Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 97. North America Genital Herpes Vaccine Sales by Country (2021-2026) & (k units) Table 98. North America Genital Herpes Vaccine Sales by Country (2027-2032) & (k units) Table 99. North America Genital Herpes Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 100. North America Genital Herpes Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 101. United States Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 102. Canada Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 103. Mexico Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 104. Europe Genital Herpes Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Genital Herpes Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Genital Herpes Vaccine Sales by Type (2021-2026) & (k units) Table 107. Europe Genital Herpes Vaccine Sales by Type (2027-2032) & (k units) Table 108. Europe Genital Herpes Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 109. Europe Genital Herpes Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 110. Europe Genital Herpes Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Genital Herpes Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Genital Herpes Vaccine Sales by Application (2021-2026) & (k units) Table 113. Europe Genital Herpes Vaccine Sales by Application (2027-2032) & (k units) Table 114. Europe Genital Herpes Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 115. Europe Genital Herpes Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 116. Europe Genital Herpes Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Genital Herpes Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe Genital Herpes Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe Genital Herpes Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 120. Europe Genital Herpes Vaccine Sales by Country (2021-2026) & (k units) Table 121. Europe Genital Herpes Vaccine Sales by Country (2027-2032) & (k units) Table 122. Europe Genital Herpes Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 123. Europe Genital Herpes Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 124. Germany Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 125. France Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 126. U.K. Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 127. Italy Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 128. Russia Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 129. Spain Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 130. Netherlands Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 131. Switzerland Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 132. Sweden Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 133. Poland Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 134. China Genital Herpes Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 135. China Genital Herpes Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 136. China Genital Herpes Vaccine Sales by Type (2021-2026) & (k units) Table 137. China Genital Herpes Vaccine Sales by Type (2027-2032) & (k units) Table 138. China Genital Herpes Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 139. China Genital Herpes Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 140. China Genital Herpes Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 141. China Genital Herpes Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 142. China Genital Herpes Vaccine Sales by Application (2021-2026) & (k units) Table 143. China Genital Herpes Vaccine Sales by Application (2027-2032) & (k units) Table 144. China Genital Herpes Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 145. China Genital Herpes Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 146. Asia Genital Herpes Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Genital Herpes Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Genital Herpes Vaccine Sales by Type (2021-2026) & (k units) Table 149. Asia Genital Herpes Vaccine Sales by Type (2027-2032) & (k units) Table 150. Asia Genital Herpes Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 151. Asia Genital Herpes Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 152. Asia Genital Herpes Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Genital Herpes Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Genital Herpes Vaccine Sales by Application (2021-2026) & (k units) Table 155. Asia Genital Herpes Vaccine Sales by Application (2027-2032) & (k units) Table 156. Asia Genital Herpes Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 157. Asia Genital Herpes Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 158. Asia Genital Herpes Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Genital Herpes Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Genital Herpes Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Genital Herpes Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 162. Asia Genital Herpes Vaccine Sales by Country (2021-2026) & (k units) Table 163. Asia Genital Herpes Vaccine Sales by Country (2027-2032) & (k units) Table 164. Asia Genital Herpes Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 165. Asia Genital Herpes Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 166. Japan Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 167. South Korea Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 168. India Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 169. Australia Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 170. Taiwan Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Genital Herpes Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Genital Herpes Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Genital Herpes Vaccine Sales by Type (2021-2026) & (k units) Table 175. SAMEA Genital Herpes Vaccine Sales by Type (2027-2032) & (k units) Table 176. SAMEA Genital Herpes Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 177. SAMEA Genital Herpes Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 178. SAMEA Genital Herpes Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Genital Herpes Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Genital Herpes Vaccine Sales by Application (2021-2026) & (k units) Table 181. SAMEA Genital Herpes Vaccine Sales by Application (2027-2032) & (k units) Table 182. SAMEA Genital Herpes Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 183. SAMEA Genital Herpes Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 184. SAMEA Genital Herpes Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Genital Herpes Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Genital Herpes Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Genital Herpes Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 188. SAMEA Genital Herpes Vaccine Sales by Country (2021-2026) & (k units) Table 189. SAMEA Genital Herpes Vaccine Sales by Country (2027-2032) & (k units) Table 190. SAMEA Genital Herpes Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 191. SAMEA Genital Herpes Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 192. Brazil Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 193. Argentina Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 194. Chile Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 195. Colombia Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 196. Peru Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 198. Israel Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 199. UAE Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 200. Turkey Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 201. Iran Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 202. Egypt Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Genital Herpes Vaccine Distributors List Table 206. Genital Herpes Vaccine Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Genital Herpes Vaccine Image Figure 2. Global Genital Herpes Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genital Herpes Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Zoster Vaccine Live Image Figure 5. Recombinant Zoster Vaccine Image Figure 6. Global Genital Herpes Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Genital Herpes Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Male Image Figure 9. Female Image Figure 10. Global Genital Herpes Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Genital Herpes Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Genital Herpes Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Genital Herpes Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Genital Herpes Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Genital Herpes Vaccine Sales (2021-2032) & (k units) Figure 16. Global Genital Herpes Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Genital Herpes Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Genital Herpes Vaccine Sales YoY (2021-2032) & (k units) Figure 19. Europe Genital Herpes Vaccine Sales YoY (2021-2032) & (k units) Figure 20. China Genital Herpes Vaccine Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Genital Herpes Vaccine Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Genital Herpes Vaccine Sales YoY (2021-2032) & (k units) Figure 23. Global Genital Herpes Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Genital Herpes Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Genital Herpes Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Genital Herpes Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Genital Herpes Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Genital Herpes Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Genital Herpes Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Genital Herpes Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Genital Herpes Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Genital Herpes Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Genital Herpes Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Genital Herpes Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Genital Herpes Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Genital Herpes Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Genital Herpes Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Genital Herpes Vaccine Sales Share by Type (2021-2032) Figure 40. North America Genital Herpes Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Genital Herpes Vaccine Sales Share by Application (2021-2032) Figure 42. North America Genital Herpes Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Genital Herpes Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Genital Herpes Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Genital Herpes Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Genital Herpes Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Genital Herpes Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Genital Herpes Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Genital Herpes Vaccine Sales Share by Country (2021-2032) Figure 50. China Genital Herpes Vaccine Revenue Share by Type (2021-2032) Figure 51. China Genital Herpes Vaccine Sales Share by Type (2021-2032) Figure 52. China Genital Herpes Vaccine Revenue Share by Application (2021-2032) Figure 53. China Genital Herpes Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Genital Herpes Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Genital Herpes Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Genital Herpes Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Genital Herpes Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Genital Herpes Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Genital Herpes Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Genital Herpes Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Genital Herpes Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Genital Herpes Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Genital Herpes Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Genital Herpes Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Genital Herpes Vaccine Sales Share by Country (2021-2032) Figure 66. Genital Herpes Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Genital Herpes Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Zoster Vaccine Live
  • Recombinant Zoster Vaccine
Applications
  • Male
  • Female
Companies covered
  • GSK
  • Changsheng Biotechnology
  • Merck
  • Beike Bio
  • BioNTech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Genital Herpes Vaccine Market by Type
  3. 1.2.1 Global Genital Herpes Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Zoster Vaccine Live
  5. 1.2.3 Recombinant Zoster Vaccine
  6. 1.3 Genital Herpes Vaccine Market by Application
  7. 1.3.1 Global Genital Herpes Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Male
  9. 1.3.3 Female
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Genital Herpes Vaccine Market Dynamics
  1. 2.1 Genital Herpes Vaccine Industry Trends
  2. 2.2 Genital Herpes Vaccine Industry Drivers
  3. 2.3 Genital Herpes Vaccine Industry Opportunities and Challenges
  4. 2.4 Genital Herpes Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Genital Herpes Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Genital Herpes Vaccine Revenue by Region
  3. 3.2.1 Global Genital Herpes Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Genital Herpes Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Genital Herpes Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Genital Herpes Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Genital Herpes Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Genital Herpes Vaccine Sales by Region
  9. 3.4.1 Global Genital Herpes Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Genital Herpes Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Genital Herpes Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Genital Herpes Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Genital Herpes Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Genital Herpes Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Genital Herpes Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Genital Herpes Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Genital Herpes Vaccine Sales by Manufacturers
  6. 4.2.1 Global Genital Herpes Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Genital Herpes Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Genital Herpes Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Genital Herpes Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Genital Herpes Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Genital Herpes Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Genital Herpes Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Genital Herpes Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Genital Herpes Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Genital Herpes Vaccine Tier 1, Tier 2, and Tier 3
5 Genital Herpes Vaccine Market by Type
  1. 5.1 Global Genital Herpes Vaccine Revenue by Type
  2. 5.1.1 Global Genital Herpes Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Genital Herpes Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Genital Herpes Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Genital Herpes Vaccine Sales by Type
  6. 5.2.1 Global Genital Herpes Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Genital Herpes Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Genital Herpes Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Genital Herpes Vaccine Price by Type
6 Genital Herpes Vaccine Market by Application
  1. 6.1 Global Genital Herpes Vaccine Revenue by Application
  2. 6.1.1 Global Genital Herpes Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Genital Herpes Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Genital Herpes Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Genital Herpes Vaccine Sales by Application
  6. 6.2.1 Global Genital Herpes Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Genital Herpes Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Genital Herpes Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Genital Herpes Vaccine Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Genital Herpes Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Genital Herpes Vaccine Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Changsheng Biotechnology
  8. 7.2.1 Changsheng Biotechnology Company Information
  9. 7.2.2 Changsheng Biotechnology Business Overview
  10. 7.2.3 Changsheng Biotechnology Genital Herpes Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Changsheng Biotechnology Genital Herpes Vaccine Product Portfolio
  12. 7.2.5 Changsheng Biotechnology Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Genital Herpes Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Genital Herpes Vaccine Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Beike Bio
  20. 7.4.1 Beike Bio Company Information
  21. 7.4.2 Beike Bio Business Overview
  22. 7.4.3 Beike Bio Genital Herpes Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Beike Bio Genital Herpes Vaccine Product Portfolio
  24. 7.4.5 Beike Bio Recent Developments
  25. 7.5 BioNTech
  26. 7.5.1 BioNTech Company Information
  27. 7.5.2 BioNTech Business Overview
  28. 7.5.3 BioNTech Genital Herpes Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 BioNTech Genital Herpes Vaccine Product Portfolio
  30. 7.5.5 BioNTech Recent Developments
8 North America
  1. 8.1 North America Genital Herpes Vaccine Market Size by Type
  2. 8.1.1 North America Genital Herpes Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Genital Herpes Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Genital Herpes Vaccine Price by Type (2021-2032)
  5. 8.2 North America Genital Herpes Vaccine Market Size by Application
  6. 8.2.1 North America Genital Herpes Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Genital Herpes Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Genital Herpes Vaccine Price by Application (2021-2032)
  9. 8.3 North America Genital Herpes Vaccine Market Size by Country
  10. 8.3.1 North America Genital Herpes Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Genital Herpes Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Genital Herpes Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Genital Herpes Vaccine Market Size by Type
  2. 9.1.1 Europe Genital Herpes Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Genital Herpes Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Genital Herpes Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Genital Herpes Vaccine Market Size by Application
  6. 9.2.1 Europe Genital Herpes Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Genital Herpes Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Genital Herpes Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Genital Herpes Vaccine Market Size by Country
  10. 9.3.1 Europe Genital Herpes Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Genital Herpes Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Genital Herpes Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Genital Herpes Vaccine Market Size by Type
  2. 10.1.1 China Genital Herpes Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Genital Herpes Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Genital Herpes Vaccine Price by Type (2021-2032)
  5. 10.2 China Genital Herpes Vaccine Market Size by Application
  6. 10.2.1 China Genital Herpes Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Genital Herpes Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Genital Herpes Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Genital Herpes Vaccine Market Size by Type
  2. 11.1.1 Asia Genital Herpes Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Genital Herpes Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Genital Herpes Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Genital Herpes Vaccine Market Size by Application
  6. 11.2.1 Asia Genital Herpes Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Genital Herpes Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Genital Herpes Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Genital Herpes Vaccine Market Size by Country
  10. 11.3.1 Asia Genital Herpes Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Genital Herpes Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Genital Herpes Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Genital Herpes Vaccine Market Size by Type
  2. 12.1.1 SAMEA Genital Herpes Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Genital Herpes Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Genital Herpes Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Genital Herpes Vaccine Market Size by Application
  6. 12.2.1 SAMEA Genital Herpes Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Genital Herpes Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Genital Herpes Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Genital Herpes Vaccine Market Size by Country
  10. 12.3.1 SAMEA Genital Herpes Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Genital Herpes Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Genital Herpes Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Genital Herpes Vaccine Value Chain Analysis
  2. 13.1.1 Genital Herpes Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Genital Herpes Vaccine Production Mode & Process
  6. 13.2 Genital Herpes Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Genital Herpes Vaccine Distributors
  9. 13.2.3 Genital Herpes Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst